SCHEMBL8729079

SCHEMBL8729079

CC(C)(C)c1ccccc1-c1c(C(N)=O)cccc1C(=O)O

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MYC P01106 1/20 0.49
KEAP1 Q14145 1/20 0.47
NFE2L2 Q16236 1/20 0.47
ALDH1A1 P00352 3/20 0.45
L3MBTL1 Q9Y468 1/20 0.45
LMNA P02545 1/20 0.45
MAPT P10636 1/20 0.45
BCAT2 O15382 1/20 0.45
PDK2 Q15119 1/20 0.43
HNF4A P41235 1/20 0.42
F2 P00734 2/20 0.39
PRSS1 P07477 2/20 0.39
PRSS2 P07478 2/20 0.39
PRSS3 P35030 2/20 0.39
POLB P06746 1/20 0.38
ALOX15 P16050 2/20 0.38
PARP1 P09874 1/20 0.38
NPC1 O15118 2/20 0.38
RAB9A P51151 2/20 0.38
HSD17B10 Q99714 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8729082 0.83 MYC (0.46) MYCKEAP1NFE2L2ALDH1A1L3MBTL1
SCHEMBL10950355 0.78 ALDH1A1 (0.47) MYCALDH1A1L3MBTL1LMNAMAPT
SCHEMBL4251057 0.78 MYC (0.47) MYCALDH1A1L3MBTL1LMNAMAPT
SCHEMBL28065800 0.77 HNF4A (0.47) MYCALDH1A1L3MBTL1LMNAMAPT
SCHEMBL5399387 0.76 HNF4A (0.59) MYCALDH1A1L3MBTL1LMNAMAPT
SCHEMBL1002129 0.76 ALDH1A1 (0.50) KEAP1NFE2L2ALDH1A1L3MBTL1MAPT
SCHEMBL11247684 0.76 GLRA3 (0.43) MYCALDH1A1MAPTBCAT2ALOX15
SCHEMBL8554492 0.75 MYC (0.51) MYCKEAP1NFE2L2ALDH1A1L3MBTL1
Bromide SCHEMBL6851251 0.75 ALDH1A1 (0.48) KEAP1NFE2L2ALDH1A1L3MBTL1MAPT
Hydrochloric Acid SCHEMBL20576674 0.75 ALDH1A1 (0.48) KEAP1NFE2L2ALDH1A1L3MBTL1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0869782-A2 METHODS OF TREATMENT WITH COMPOUNDS HAVING RAR $g(a)? RECEPTOR SPECIFIC OR SELECTIVE ACTIVITY Vision Pharmaceuticals L.P. (US) 1998-10-14 EP disclosed
WO-1997024116-A2 METHODS OF TREATMENT WITH COMPOUNDS HAVING RARα RECEPTOR SPECIFIC OR SELECTIVE ACTIVITY VISION PHARMACEUTICALS L.P. (US) 1997-07-10 WO disclosed